Details for New Drug Application (NDA): 017425
✉ Email this page to a colleague
NDA 017425 describes PROGLYCEM, which is a drug marketed by Teva Branded Pharm and is included in two NDAs. It is available from one supplier. Additional details are available on the PROGLYCEM profile page.
The generic ingredient in PROGLYCEM is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
The generic ingredient in PROGLYCEM is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
Summary for 017425
| Tradename: | PROGLYCEM |
| Applicant: | Teva Branded Pharm |
| Ingredient: | diazoxide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017425
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
